Bundamedik Tbk vs Sinarmas Multiartha Tbk. — how do they compare? Bundamedik Tbk trades at Rp176 (market cap 1.51T, 536.7K 24h volume), while Sinarmas Multiartha Tbk. trades at Rp20,700 (market cap 131.65T, 3K 24h volume). The key difference: Sinarmas Multiartha Tbk. is far larger — about 87.2× Bundamedik Tbk's market cap, and Bundamedik Tbk is more actively traded (536.7K versus 3K). Which is the better fit depends on your goals.
| BMHS | SMMA | |
|---|---|---|
Market Cap | 1.51T | 131.65T |
Volume | 536.7K | 3K |
Lot | 5.37K | 30 |
Turnover | 93.41M | 60.98M |
Average Price | 174.05 | 20,325.83 |
Value | 93.41M | 60.98M |
Indicative Equilibrium Price | 176 | 20,675 |
Indicative Equilibrium Volume | 100 | 1 |
Trailing returns across standard periods
Latest headlines on both assets
PT Bundamedik Tbk (the “Company”) was established on 13 April 1978 based on Notarial Deed No. 21 of Adlan Yulizar, S.H. The Company strated its commercial operations in 1978. The Company’s parent and ultimate parent of the group is PT Bunda Investama Indonesia.
Read more on BMHS →PT Sinar Mas Multiartha Tbk was established by Deed No. 60 dated October 21, 1982 from Benny Kristianto, S.H., notary in Jakarta. PT Sinar Mas Multiartha was initially active in commercial leasing, consumer financing and venture capital, and purely became a holding company in the Sinar Mas Group.
Read more on SMMA →